With so many clinical innovations abound, it's easy to get excited about groundbreaking drugs, consumer technologies and even possible cures for rare diseases. However, the industry must recognize its own limitations in order to make these advancements accessible and equitable.
At the end of August, hundreds of healthcare leaders gathered at Advisory Board's Clinical Innovation Summit in Minneapolis to learn about the implications of the transformation of patient care across the industry. The Radio Advisory team orchestrated a live podcast recording with thought leaders across the industry to talk about embedding equity in innovation.
In this special live episode of Radio Advisory, host Rachel (Rae) Woods invites Maia Laing, SVP of Health Equity for UnitedHealth Group, and Michael Mejia, Advisory Board's director of life sciences research, to discuss how leaders can think about deploying, designing, and financing clinical innovations in an equitable way. Throughout the conversation, they discuss how payers and providers – not just life sciences – can rethink their practices to ensure advancements in innovation are shared equitably.
Links:

Dive into topics like AI and weight management drugs at Advisory Board’s Virtual Clinical Innovation Summit, coming up on October 4-5. Learn more and register.
7 trends shaping life sciences strategies in 2023
Health Equity landing page
Learn more about Advisory Board Summits


Need a quick answer to a healthcare question? Ask Advisory! Whether it's about where the market is headed, or how to navigate our website our team of experts are just a call or email away. Visit ask.advisory.com or email ask@advisory.com to learn more.
Advisory Board is a subsidiary of UnitedHealth Group. All Advisory Board research, expert perspectives, and recommendations remain independent.